Complete profile

Third-Party Information Liability Disclaimer

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Last Updated: 2011-03-28

Afexa Life Sciences Inc

Company information

Legal Name:   Afexa Life Sciences Inc
Operating Name:   Afexa Life Sciences Inc
Mailing Address
9604, 20 Ave NW
T6N 1G1
Location Address
9604, 20 Ave NW
T6N 1G1
Telephone: (780) 432-0022
Toll Free Phone: 1-888-280-0022
Fax: (780) 432-7772
Website URL: 

Contact information

Jack Moffatt
  Title:   Chief Executive Officer
  Area of Responsibility:   Management Executive
Allan Cleiren
  Title:   Chief Financial Officer
  Area of Responsibility:   Finance/Accounting
Tracey Ramsay
  Title:   Chief Marketing Officer and Senior VP Sales
Jane Tulloch
  Title:   Senior Director, Board Affairs and Investor Relations
  Telephone:   (780) 577-3724
Jacqueline Shan
  Title:   Chief Scientific Officer
Michael Obert
  Title:   Chief Legal Officer and Senior VP Corporate Development


Company description

Afexa Life Sciences Inc. develops and manufacturers evidence-based natural health products for disease prevention and health maintenance. The company has developed, commercialized, and patented a proprietary technology, known as ChemBioPrint, used to discover and biologically standardize natural products that deliver consistent, verifiable and provable health benefits.

Afexa Life Sciences Inc. is committed to using a pharmaceutical model with rigorous drug discovery and testing methods to develop natural therapeutics for health maintenance and disease prevention. Its efforts in scientific research and product innovation are key factors enabling the company to secure the trust of consumers, healthcare practitioners and government. Products include COLD-FX®, IMMUNITY-FX®, REMEMBER-FX®, CELL-FX®, and MEMORY-FX®.
Country of Ownership: Canada  
Year Established: 1992
Exporting: Yes  
Primary Industry (NAICS): 541710 - Research and Development in the Physical, Engineering and Life Sciences
Alternate Industries (NAICS): 325410 - Pharmaceutical and Medicine Manufacturing
Primary Business Activity: Manufacturer / Processor / Producer  
Total Sales ($CDN): $50,000,000 + 
Export Sales ($CDN): $1,000,000 to $4,999,999 
Number of Employees: 120 


Product / Service / Licensing

Product Name: CELL-FX
Helps relieve symptoms of bone and joint pain and helps in the formation of connective tissue.

Product Name: COLD-FX
Helps reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system.

Product Name: IMMUNITY-FX
IMMUNITY-FX is scientifically proven to provide health benefits by enhancing the immune system.

Product Name: MEMORY-FX
Improves mental sharpness and enhances overall brain function.

Product Name: REMEMBER-FX
Enhances memory and mental alertness.



Technology profile

ChemBioPrint is a technology platform allowing Afexa Life Sciences to formulate and standardize natural health products which have proven health benefits. It is a process that uses a series of chemical and functional/biological assays to characterize specific mixtures and multiple components of natural substances. This ‘two-dimensional’ characterization provides assurance to the consumer that our ChemBioPrint products have precise identities, and are guaranteed to be effective.


Market profile


  • Financial
  • Sales/Marketing
  • Technology

Strategic alliances:

To select pharmaceutical and biotechnology companies where
such alliances may expand Afexa Life Sciences Inc.'s research, development and
marketing capabilities.

Actively seeking distributors across the world, as well as
financial alliances to expand operation/production development.

Afexa Life Sciences is seeking to license products that fit Afexa's profile from third parties.

Industry sector market interests:

  • Medical/Biotechnology/Chemical

Geographic markets:

Export experience:
  • Hong Kong
  • United States
Actively pursuing:
  • China
  • United Kingdom


Note: This document is presented in the language provided by the author/source. Most of the information contained in Canadian Company Capabilities (CCC) has been provided by sources external to Industry Canada. The accuracy, currency and reliability of the information contained in CCC are the sole responsibility of the registered companies and related organizations. Industry Canada assumes no responsibility in this respect. The registered businesses shall ensure the continued monitoring of the information contained in CCC and ask that it be modified when necessary.